The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3-((4-amino-6-((3-chloro-4-methylphenyl)amino)-1,3,5-triazin-2-yl)methoxy)-5-(trifluoromethyl)phenyl)pyrrolidin-2-one ID: ALA5286632
Max Phase: Preclinical
Molecular Formula: C22H20ClF3N6O2
Molecular Weight: 492.89
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(Nc2nc(N)nc(COc3cc(N4CCCC4=O)cc(C(F)(F)F)c3)n2)cc1Cl
Standard InChI: InChI=1S/C22H20ClF3N6O2/c1-12-4-5-14(9-17(12)23)28-21-30-18(29-20(27)31-21)11-34-16-8-13(22(24,25)26)7-15(10-16)32-6-2-3-19(32)33/h4-5,7-10H,2-3,6,11H2,1H3,(H3,27,28,29,30,31)
Standard InChI Key: IYTHMFHSOULRPV-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 37 0 0 0 0 0 0 0 0999 V2000
-4.5947 -0.6190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8801 -0.2067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1682 -0.6186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1682 -1.4437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8783 -1.8555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5947 -1.4474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3093 -1.8601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4536 -0.2060 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7389 -0.6186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0241 -0.2061 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3120 -0.6182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3120 -1.4436 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0223 -1.8555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7389 -1.4473 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0223 -2.6807 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4025 -0.2056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1172 -0.6182 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8318 -0.2056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8320 0.6195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5449 1.0302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2597 0.6175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2613 -0.2034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5495 -0.6199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9759 -0.6161 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6906 -0.2035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3093 -0.7748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9786 -1.5093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1545 -1.4170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5710 -2.0005 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.3093 -0.2063 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.5449 1.8555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8303 2.2680 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.2595 2.2680 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.5449 2.6807 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
6 7 1 0
3 8 1 0
8 9 1 0
10 9 2 0
11 10 1 0
12 11 2 0
13 12 1 0
14 13 2 0
9 14 1 0
13 15 1 0
11 16 1 0
16 17 1 0
17 18 1 0
19 18 2 0
20 19 1 0
21 20 2 0
22 21 1 0
23 22 2 0
18 23 1 0
24 22 1 0
24 25 1 0
25 26 1 0
26 27 1 0
28 27 1 0
24 28 1 0
28 29 2 0
1 30 1 0
20 31 1 0
31 32 1 0
31 33 1 0
31 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 492.89Molecular Weight (Monoisotopic): 492.1288AlogP: 4.88#Rotatable Bonds: 6Polar Surface Area: 106.26Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.66CX Basic pKa: 4.10CX LogP: 4.86CX LogD: 4.86Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.50Np Likeness Score: -2.02
References 1. Lückmann M, Shenol A, Nissen TAD, Petersen JE, Kouvchinov D, Schwartz TW, Frimurer TM.. (2022) Optimization of First-in-Class Dual-Acting FFAR1/FFAR4 Allosteric Modulators with Novel Mode of Action., 13 (12.0): [PMID:36518697 ] [10.1021/acsmedchemlett.2c00160 ]